1h Free Analyst Time
The global anterior uveitis treatment market is forecasted to grow by USD 140.26 million during 2025-2030, accelerating at a CAGR of 4.5% during the forecast period. The report on the global anterior uveitis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global incidence of systemic autoimmune conditions, regulatory support and incentives for orphan ophthalmic drugs, expansion of advanced ophthalmic surgical infrastructure globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global anterior uveitis treatment market is segmented as below:
By Type
- Medications
- Surgery
By Disease Type
- Infectious uveitis
- Non-infectious uveitis
By Drug Class
- Corticosteroids
- Biologics and Biosimilars
- Others
Geography
- North America
- US
- Canada
- Mexico
- Asia
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Rest of World (ROW)
- Rest of World (ROW)
The report on the global anterior uveitis treatment market covers the following areas:
- Global anterior uveitis treatment market sizing
- Global anterior uveitis treatment market forecast
- Global anterior uveitis treatment market industry analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Anterior Uveitis Treatment Market 2020 - 2024
- Historic Market Size - Data Table on Global Anterior Uveitis Treatment Market 2020 - 2024 ($ thousand)
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Disease Type Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Drug Class Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
6.1 Impact of AI on global anterior uveitis treatment market
6.2 Impact of geopolitical conflicts on global anterior uveitis treatment market
6.2 Impact of geopolitical conflicts on global anterior uveitis treatment market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2025-2030 (%)
- Data Table on Type - Market share 2025-2030 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Medications - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Medications - Market size and forecast 2025-2030 ($ thousand)
- Chart on Medications - Year-over-year growth 2025-2030 (%)
- Data Table on Medications - Year-over-year growth 2025-2030 (%)
- Chart on Surgery - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Surgery - Market size and forecast 2025-2030 ($ thousand)
- Chart on Surgery - Year-over-year growth 2025-2030 (%)
- Data Table on Surgery - Year-over-year growth 2025-2030 (%)
- Market opportunity by Type ($ thousand)
- Data Table on Market opportunity by Type ($ thousand)
9 Market Segmentation by Disease Type
9.1 Market segments
- Chart on Disease Type - Market share 2025-2030 (%)
- Data Table on Disease Type - Market share 2025-2030 (%)
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
- Chart on Infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
- Chart on Infectious uveitis - Year-over-year growth 2025-2030 (%)
- Data Table on Infectious uveitis - Year-over-year growth 2025-2030 (%)
- Chart on Non-infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Non-infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
- Chart on Non-infectious uveitis - Year-over-year growth 2025-2030 (%)
- Data Table on Non-infectious uveitis - Year-over-year growth 2025-2030 (%)
- Market opportunity by Disease Type ($ thousand)
- Data Table on Market opportunity by Disease Type ($ thousand)
10 Market Segmentation by Drug Class
10.1 Market segments
- Chart on Drug Class - Market share 2025-2030 (%)
- Data Table on Drug Class - Market share 2025-2030 (%)
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- Chart on Corticosteroids - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Corticosteroids - Market size and forecast 2025-2030 ($ thousand)
- Chart on Corticosteroids - Year-over-year growth 2025-2030 (%)
- Data Table on Corticosteroids - Year-over-year growth 2025-2030 (%)
- Chart on Biologics and Biosimilars - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Biologics and Biosimilars - Market size and forecast 2025-2030 ($ thousand)
- Chart on Biologics and Biosimilars - Year-over-year growth 2025-2030 (%)
- Data Table on Biologics and Biosimilars - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Drug Class ($ thousand)
- Data Table on Market opportunity by Drug Class ($ thousand)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ thousand)
- Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ thousand)
- Data Table on US - Market size and forecast 2025-2030 ($ thousand)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ thousand)
- Data Table on China - Market size and forecast 2025-2030 ($ thousand)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ thousand)
- Data Table on India - Market size and forecast 2025-2030 ($ thousand)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ thousand)
- Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ thousand)
- Data Table on France - Market size and forecast 2025-2030 ($ thousand)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
- Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
- Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
- Chart on Israel - Year-over-year growth 2025-2030 (%)
- Data Table on Israel - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Rising global incidence of systemic autoimmune conditions
- Regulatory support and incentives for orphan ophthalmic drugs
- Expansion of advanced ophthalmic surgical infrastructure globally
- Steroid induced ocular complications and adverse safety profiles
- Patient non compliance and topical administration complexities
- High economic burden of advanced biologic interventions
- Impact of drivers and challenges in 2025 and 2030
- Shift toward non steroidal macrophage modulating therapeutics
- Development of sustained release intracameral drug delivery
- Adoption of digital anterior chamber imaging technologies
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
- ANI Pharmaceuticals Inc. - Overview
- ANI Pharmaceuticals Inc. - Product / Service
- ANI Pharmaceuticals Inc. - Key offerings
- SWOT
- Bausch Lomb Corp. - Overview
- Bausch Lomb Corp. - Business segments
- Bausch Lomb Corp. - Key news
- Bausch Lomb Corp. - Key offerings
- Bausch Lomb Corp. - Segment focus
- SWOT
- Cadila Pharmaceuticals Ltd. - Overview
- Cadila Pharmaceuticals Ltd. - Product / Service
- Cadila Pharmaceuticals Ltd. - Key offerings
- SWOT
- Dr. Reddys Laboratories Ltd. - Overview
- Dr. Reddys Laboratories Ltd. - Business segments
- Dr. Reddys Laboratories Ltd. - Key news
- Dr. Reddys Laboratories Ltd. - Key offerings
- Dr. Reddys Laboratories Ltd. - Segment focus
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
- SWOT
- Johnson and Johnson - Overview
- Johnson and Johnson - Business segments
- Johnson and Johnson - Key news
- Johnson and Johnson - Key offerings
- Johnson and Johnson - Segment focus
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key news
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
- Sandoz Group AG - Overview
- Sandoz Group AG - Business segments
- Sandoz Group AG - Key news
- Sandoz Group AG - Key offerings
- Sandoz Group AG - Segment focus
- SWOT
- Santen Pharmaceutical Co. Ltd. - Overview
- Santen Pharmaceutical Co. Ltd. - Product / Service
- Santen Pharmaceutical Co. Ltd. - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Anterior Uveitis Treatment Market 2020 - 2024 ($ thousand)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
Exhibit 27: Historic Market Size - Disease Type Segment 2020 - 2024 ($ thousand)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ thousand)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Medications - Market size and forecast 2025-2030 ($ thousand)
Exhibit 43: Data Table on Medications - Market size and forecast 2025-2030 ($ thousand)
Exhibit 44: Chart on Medications - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Medications - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Surgery - Market size and forecast 2025-2030 ($ thousand)
Exhibit 47: Data Table on Surgery - Market size and forecast 2025-2030 ($ thousand)
Exhibit 48: Chart on Surgery - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Surgery - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Type ($ thousand)
Exhibit 51: Data Table on Market opportunity by Type ($ thousand)
Exhibit 52: Chart on Disease Type - Market share 2025-2030 (%)
Exhibit 53: Data Table on Disease Type - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Disease Type
Exhibit 55: Data Table on Comparison by Disease Type
Exhibit 56: Chart on Infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
Exhibit 57: Data Table on Infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
Exhibit 58: Chart on Infectious uveitis - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Infectious uveitis - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Non-infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
Exhibit 61: Data Table on Non-infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
Exhibit 62: Chart on Non-infectious uveitis - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Non-infectious uveitis - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Disease Type ($ thousand)
Exhibit 65: Data Table on Market opportunity by Disease Type ($ thousand)
Exhibit 66: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 67: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Drug Class
Exhibit 69: Data Table on Comparison by Drug Class
Exhibit 70: Chart on Corticosteroids - Market size and forecast 2025-2030 ($ thousand)
Exhibit 71: Data Table on Corticosteroids - Market size and forecast 2025-2030 ($ thousand)
Exhibit 72: Chart on Corticosteroids - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Corticosteroids - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Biologics and Biosimilars - Market size and forecast 2025-2030 ($ thousand)
Exhibit 75: Data Table on Biologics and Biosimilars - Market size and forecast 2025-2030 ($ thousand)
Exhibit 76: Chart on Biologics and Biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Biologics and Biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 79: Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 80: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 82: Market opportunity by Drug Class ($ thousand)
Exhibit 83: Data Table on Market opportunity by Drug Class ($ thousand)
Exhibit 84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 85: Chart on Market share by geography 2025-2030 (%)
Exhibit 86: Data Table on Market share by geography 2025-2030 (%)
Exhibit 87: Chart on Geographic comparison
Exhibit 88: Data Table on Geographic comparison
Exhibit 89: Chart on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 90: Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 91: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 92: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 93: Chart on Regional Comparison - North America
Exhibit 94: Data Table on Regional Comparison - North America
Exhibit 95: Chart on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 96: Data Table on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 97: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 99: Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 100: Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 101: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 104: Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 105: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 108: Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 109: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Regional Comparison - Asia
Exhibit 112: Data Table on Regional Comparison - Asia
Exhibit 113: Chart on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 114: Data Table on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 115: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 118: Data Table on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 119: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 122: Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 123: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 126: Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 127: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 130: Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 131: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 134: Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 135: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 138: Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 139: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Regional Comparison - Europe
Exhibit 142: Data Table on Regional Comparison - Europe
Exhibit 143: Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 144: Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 145: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 148: Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 149: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 152: Data Table on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 153: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 156: Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 157: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 160: Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 161: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 164: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 165: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 168: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 169: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 172: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 173: Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 174: Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 175: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 178: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 179: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 182: Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 183: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 186: Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 187: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 190: Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 191: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 194: Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 195: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 198: Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 199: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 202: Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 203: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 205: Market opportunity by geography ($ thousand)
Exhibit 206: Data Tables on Market opportunity by geography ($ thousand)
Exhibit 207: Impact of drivers and challenges in 2025 and 2030
Exhibit 208: Overview on criticality of inputs and factors of differentiation
Exhibit 209: Overview on factors of disruption
Exhibit 210: Impact of key risks on business
Exhibit 211: Companies covered
Exhibit 212: Company ranking index
Exhibit 213: Matrix on companies position and classification
Exhibit 214: AbbVie Inc. - Overview
Exhibit 215: AbbVie Inc. - Business segments
Exhibit 216: AbbVie Inc. - Key news
Exhibit 217: AbbVie Inc. - Key offerings
Exhibit 218: AbbVie Inc. - Segment focus
Exhibit 219: SWOT
Exhibit 220: Amgen Inc. - Overview
Exhibit 221: Amgen Inc. - Product / Service
Exhibit 222: Amgen Inc. - Key news
Exhibit 223: Amgen Inc. - Key offerings
Exhibit 224: SWOT
Exhibit 225: ANI Pharmaceuticals Inc. - Overview
Exhibit 226: ANI Pharmaceuticals Inc. - Product / Service
Exhibit 227: ANI Pharmaceuticals Inc. - Key offerings
Exhibit 228: SWOT
Exhibit 229: Bausch Lomb Corp. - Overview
Exhibit 230: Bausch Lomb Corp. - Business segments
Exhibit 231: Bausch Lomb Corp. - Key news
Exhibit 232: Bausch Lomb Corp. - Key offerings
Exhibit 233: Bausch Lomb Corp. - Segment focus
Exhibit 234: SWOT
Exhibit 235: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 236: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 237: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibit 238: SWOT
Exhibit 239: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 240: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 241: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 242: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 243: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 244: SWOT
Exhibit 245: F. Hoffmann La Roche Ltd. - Overview
Exhibit 246: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 247: F. Hoffmann La Roche Ltd. - Key news
Exhibit 248: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 249: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 250: SWOT
Exhibit 251: Hikma Pharmaceuticals Plc - Overview
Exhibit 252: Hikma Pharmaceuticals Plc - Business segments
Exhibit 253: Hikma Pharmaceuticals Plc - Key news
Exhibit 254: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 255: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 256: SWOT
Exhibit 257: Johnson and Johnson - Overview
Exhibit 258: Johnson and Johnson - Business segments
Exhibit 259: Johnson and Johnson - Key news
Exhibit 260: Johnson and Johnson - Key offerings
Exhibit 261: Johnson and Johnson - Segment focus
Exhibit 262: SWOT
Exhibit 263: Lupin Ltd. - Overview
Exhibit 264: Lupin Ltd. - Business segments
Exhibit 265: Lupin Ltd. - Key news
Exhibit 266: Lupin Ltd. - Key offerings
Exhibit 267: Lupin Ltd. - Segment focus
Exhibit 268: SWOT
Exhibit 269: Novartis AG - Overview
Exhibit 270: Novartis AG - Business segments
Exhibit 271: Novartis AG - Key news
Exhibit 272: Novartis AG - Key offerings
Exhibit 273: Novartis AG - Segment focus
Exhibit 274: SWOT
Exhibit 275: Pfizer Inc. - Overview
Exhibit 276: Pfizer Inc. - Business segments
Exhibit 277: Pfizer Inc. - Key news
Exhibit 278: Pfizer Inc. - Key offerings
Exhibit 279: Pfizer Inc. - Segment focus
Exhibit 280: SWOT
Exhibit 281: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 282: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 283: Regeneron Pharmaceuticals Inc. - Key news
Exhibit 284: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibit 285: SWOT
Exhibit 286: Sandoz Group AG - Overview
Exhibit 287: Sandoz Group AG - Business segments
Exhibit 288: Sandoz Group AG - Key news
Exhibit 289: Sandoz Group AG - Key offerings
Exhibit 290: Sandoz Group AG - Segment focus
Exhibit 291: SWOT
Exhibit 292: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 293: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibit 294: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibit 295: SWOT
Exhibit 296: Inclusions checklist
Exhibit 297: Exclusions checklist
Exhibit 298: Currency conversion rates for US$
Exhibit 299: Research methodology
Exhibit 300: Information sources
Exhibit 301: Data validation
Exhibit 302: Validation techniques employed for market sizing
Exhibit 303: Data synthesis
Exhibit 304: 360 degree market analysis
Exhibit 305: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ thousand)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Anterior Uveitis Treatment Market 2020 - 2024 ($ thousand)
Exhibit 26: Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
Exhibit 27: Historic Market Size - Disease Type Segment 2020 - 2024 ($ thousand)
Exhibit 28: Historic Market Size - Drug Class Segment 2020 - 2024 ($ thousand)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Type - Market share 2025-2030 (%)
Exhibit 39: Data Table on Type - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Medications - Market size and forecast 2025-2030 ($ thousand)
Exhibit 43: Data Table on Medications - Market size and forecast 2025-2030 ($ thousand)
Exhibit 44: Chart on Medications - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Medications - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Surgery - Market size and forecast 2025-2030 ($ thousand)
Exhibit 47: Data Table on Surgery - Market size and forecast 2025-2030 ($ thousand)
Exhibit 48: Chart on Surgery - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Surgery - Year-over-year growth 2025-2030 (%)
Exhibit 50: Market opportunity by Type ($ thousand)
Exhibit 51: Data Table on Market opportunity by Type ($ thousand)
Exhibit 52: Chart on Disease Type - Market share 2025-2030 (%)
Exhibit 53: Data Table on Disease Type - Market share 2025-2030 (%)
Exhibit 54: Chart on Comparison by Disease Type
Exhibit 55: Data Table on Comparison by Disease Type
Exhibit 56: Chart on Infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
Exhibit 57: Data Table on Infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
Exhibit 58: Chart on Infectious uveitis - Year-over-year growth 2025-2030 (%)
Exhibit 59: Data Table on Infectious uveitis - Year-over-year growth 2025-2030 (%)
Exhibit 60: Chart on Non-infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
Exhibit 61: Data Table on Non-infectious uveitis - Market size and forecast 2025-2030 ($ thousand)
Exhibit 62: Chart on Non-infectious uveitis - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Non-infectious uveitis - Year-over-year growth 2025-2030 (%)
Exhibit 64: Market opportunity by Disease Type ($ thousand)
Exhibit 65: Data Table on Market opportunity by Disease Type ($ thousand)
Exhibit 66: Chart on Drug Class - Market share 2025-2030 (%)
Exhibit 67: Data Table on Drug Class - Market share 2025-2030 (%)
Exhibit 68: Chart on Comparison by Drug Class
Exhibit 69: Data Table on Comparison by Drug Class
Exhibit 70: Chart on Corticosteroids - Market size and forecast 2025-2030 ($ thousand)
Exhibit 71: Data Table on Corticosteroids - Market size and forecast 2025-2030 ($ thousand)
Exhibit 72: Chart on Corticosteroids - Year-over-year growth 2025-2030 (%)
Exhibit 73: Data Table on Corticosteroids - Year-over-year growth 2025-2030 (%)
Exhibit 74: Chart on Biologics and Biosimilars - Market size and forecast 2025-2030 ($ thousand)
Exhibit 75: Data Table on Biologics and Biosimilars - Market size and forecast 2025-2030 ($ thousand)
Exhibit 76: Chart on Biologics and Biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 77: Data Table on Biologics and Biosimilars - Year-over-year growth 2025-2030 (%)
Exhibit 78: Chart on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 79: Data Table on Others - Market size and forecast 2025-2030 ($ thousand)
Exhibit 80: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 82: Market opportunity by Drug Class ($ thousand)
Exhibit 83: Data Table on Market opportunity by Drug Class ($ thousand)
Exhibit 84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 85: Chart on Market share by geography 2025-2030 (%)
Exhibit 86: Data Table on Market share by geography 2025-2030 (%)
Exhibit 87: Chart on Geographic comparison
Exhibit 88: Data Table on Geographic comparison
Exhibit 89: Chart on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 90: Data Table on North America - Market size and forecast 2025-2030 ($ thousand)
Exhibit 91: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 92: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 93: Chart on Regional Comparison - North America
Exhibit 94: Data Table on Regional Comparison - North America
Exhibit 95: Chart on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 96: Data Table on US - Market size and forecast 2025-2030 ($ thousand)
Exhibit 97: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 99: Chart on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 100: Data Table on Canada - Market size and forecast 2025-2030 ($ thousand)
Exhibit 101: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 103: Chart on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 104: Data Table on Mexico - Market size and forecast 2025-2030 ($ thousand)
Exhibit 105: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 106: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 107: Chart on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 108: Data Table on Asia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 109: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 110: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 111: Chart on Regional Comparison - Asia
Exhibit 112: Data Table on Regional Comparison - Asia
Exhibit 113: Chart on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 114: Data Table on China - Market size and forecast 2025-2030 ($ thousand)
Exhibit 115: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 118: Data Table on India - Market size and forecast 2025-2030 ($ thousand)
Exhibit 119: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 120: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 121: Chart on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 122: Data Table on Japan - Market size and forecast 2025-2030 ($ thousand)
Exhibit 123: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 124: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 125: Chart on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 126: Data Table on South Korea - Market size and forecast 2025-2030 ($ thousand)
Exhibit 127: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 128: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 129: Chart on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 130: Data Table on Indonesia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 131: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 134: Data Table on Thailand - Market size and forecast 2025-2030 ($ thousand)
Exhibit 135: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 138: Data Table on Europe - Market size and forecast 2025-2030 ($ thousand)
Exhibit 139: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Regional Comparison - Europe
Exhibit 142: Data Table on Regional Comparison - Europe
Exhibit 143: Chart on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 144: Data Table on Germany - Market size and forecast 2025-2030 ($ thousand)
Exhibit 145: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 146: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 147: Chart on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 148: Data Table on UK - Market size and forecast 2025-2030 ($ thousand)
Exhibit 149: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 150: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 151: Chart on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 152: Data Table on France - Market size and forecast 2025-2030 ($ thousand)
Exhibit 153: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 154: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 155: Chart on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 156: Data Table on Italy - Market size and forecast 2025-2030 ($ thousand)
Exhibit 157: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 158: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 159: Chart on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 160: Data Table on Spain - Market size and forecast 2025-2030 ($ thousand)
Exhibit 161: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 162: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 163: Chart on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 164: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ thousand)
Exhibit 165: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 168: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ thousand)
Exhibit 169: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 172: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 173: Chart on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 174: Data Table on Brazil - Market size and forecast 2025-2030 ($ thousand)
Exhibit 175: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 176: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 177: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 178: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 179: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 180: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 181: Chart on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 182: Data Table on UAE - Market size and forecast 2025-2030 ($ thousand)
Exhibit 183: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 184: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 185: Chart on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 186: Data Table on Turkey - Market size and forecast 2025-2030 ($ thousand)
Exhibit 187: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 188: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 189: Chart on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 190: Data Table on Argentina - Market size and forecast 2025-2030 ($ thousand)
Exhibit 191: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 192: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 193: Chart on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 194: Data Table on Colombia - Market size and forecast 2025-2030 ($ thousand)
Exhibit 195: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 196: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 197: Chart on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 198: Data Table on South Africa - Market size and forecast 2025-2030 ($ thousand)
Exhibit 199: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 202: Data Table on Israel - Market size and forecast 2025-2030 ($ thousand)
Exhibit 203: Chart on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Israel - Year-over-year growth 2025-2030 (%)
Exhibit 205: Market opportunity by geography ($ thousand)
Exhibit 206: Data Tables on Market opportunity by geography ($ thousand)
Exhibit 207: Impact of drivers and challenges in 2025 and 2030
Exhibit 208: Overview on criticality of inputs and factors of differentiation
Exhibit 209: Overview on factors of disruption
Exhibit 210: Impact of key risks on business
Exhibit 211: Companies covered
Exhibit 212: Company ranking index
Exhibit 213: Matrix on companies position and classification
Exhibit 214: AbbVie Inc. - Overview
Exhibit 215: AbbVie Inc. - Business segments
Exhibit 216: AbbVie Inc. - Key news
Exhibit 217: AbbVie Inc. - Key offerings
Exhibit 218: AbbVie Inc. - Segment focus
Exhibit 219: SWOT
Exhibit 220: Amgen Inc. - Overview
Exhibit 221: Amgen Inc. - Product / Service
Exhibit 222: Amgen Inc. - Key news
Exhibit 223: Amgen Inc. - Key offerings
Exhibit 224: SWOT
Exhibit 225: ANI Pharmaceuticals Inc. - Overview
Exhibit 226: ANI Pharmaceuticals Inc. - Product / Service
Exhibit 227: ANI Pharmaceuticals Inc. - Key offerings
Exhibit 228: SWOT
Exhibit 229: Bausch Lomb Corp. - Overview
Exhibit 230: Bausch Lomb Corp. - Business segments
Exhibit 231: Bausch Lomb Corp. - Key news
Exhibit 232: Bausch Lomb Corp. - Key offerings
Exhibit 233: Bausch Lomb Corp. - Segment focus
Exhibit 234: SWOT
Exhibit 235: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 236: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 237: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibit 238: SWOT
Exhibit 239: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 240: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 241: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 242: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 243: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 244: SWOT
Exhibit 245: F. Hoffmann La Roche Ltd. - Overview
Exhibit 246: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 247: F. Hoffmann La Roche Ltd. - Key news
Exhibit 248: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 249: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 250: SWOT
Exhibit 251: Hikma Pharmaceuticals Plc - Overview
Exhibit 252: Hikma Pharmaceuticals Plc - Business segments
Exhibit 253: Hikma Pharmaceuticals Plc - Key news
Exhibit 254: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 255: Hikma Pharmaceuticals Plc - Segment focus
Exhibit 256: SWOT
Exhibit 257: Johnson and Johnson - Overview
Exhibit 258: Johnson and Johnson - Business segments
Exhibit 259: Johnson and Johnson - Key news
Exhibit 260: Johnson and Johnson - Key offerings
Exhibit 261: Johnson and Johnson - Segment focus
Exhibit 262: SWOT
Exhibit 263: Lupin Ltd. - Overview
Exhibit 264: Lupin Ltd. - Business segments
Exhibit 265: Lupin Ltd. - Key news
Exhibit 266: Lupin Ltd. - Key offerings
Exhibit 267: Lupin Ltd. - Segment focus
Exhibit 268: SWOT
Exhibit 269: Novartis AG - Overview
Exhibit 270: Novartis AG - Business segments
Exhibit 271: Novartis AG - Key news
Exhibit 272: Novartis AG - Key offerings
Exhibit 273: Novartis AG - Segment focus
Exhibit 274: SWOT
Exhibit 275: Pfizer Inc. - Overview
Exhibit 276: Pfizer Inc. - Business segments
Exhibit 277: Pfizer Inc. - Key news
Exhibit 278: Pfizer Inc. - Key offerings
Exhibit 279: Pfizer Inc. - Segment focus
Exhibit 280: SWOT
Exhibit 281: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 282: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 283: Regeneron Pharmaceuticals Inc. - Key news
Exhibit 284: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibit 285: SWOT
Exhibit 286: Sandoz Group AG - Overview
Exhibit 287: Sandoz Group AG - Business segments
Exhibit 288: Sandoz Group AG - Key news
Exhibit 289: Sandoz Group AG - Key offerings
Exhibit 290: Sandoz Group AG - Segment focus
Exhibit 291: SWOT
Exhibit 292: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 293: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibit 294: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibit 295: SWOT
Exhibit 296: Inclusions checklist
Exhibit 297: Exclusions checklist
Exhibit 298: Currency conversion rates for US$
Exhibit 299: Research methodology
Exhibit 300: Information sources
Exhibit 301: Data validation
Exhibit 302: Validation techniques employed for market sizing
Exhibit 303: Data synthesis
Exhibit 304: 360 degree market analysis
Exhibit 305: List of abbreviations
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- ANI Pharmaceuticals Inc.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Bausch Lomb Corp.
- Cadila Pharmaceuticals Ltd.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- Hikma Pharmaceuticals Plc
- Johnson and Johnson
- Lupin Ltd.
- Mankind Pharma Ltd.
- Novartis AG
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sandoz Group AG
- Santen Pharmaceutical Co. Ltd.
